We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSIT icon
1151
Insight Enterprises
NSIT
$4.6B
$757K 0.01%
15,396
PMT
1152
PennyMac Mortgage Investment
PMT
$828M
$757K 0.01%
43,204
CALY
1153
Callaway Golf Company
CALY
$2.95B
$756K 0.01%
43,200
SANM icon
1154
Sanmina
SANM
$11.1B
$755K 0.01%
30,166
FTI icon
1155
TechnipFMC
FTI
$30.1B
$752K 0.01%
147,843
+2,258
+2% +$13.2K
APPN icon
1156
Appian
APPN
$2.65B
$752K 0.01%
14,675
CVCO icon
1157
Cavco Industries
CVCO
$4.67B
$751K 0.01%
3,896
HUBG icon
1158
HUB Group
HUBG
$2.55B
$747K 0.01%
31,236
+3,728
+14% +$86.1K
CNS icon
1159
Cohen & Steers
CNS
$4.4B
$747K 0.01%
10,982
+1,289
+13% +$77.7K
MED icon
1160
Medifast
MED
$128M
$745K 0.01%
5,370
PLMR icon
1161
Palomar
PLMR
$3.37B
$745K 0.01%
8,685
+655
+8% +$43.5K
HL icon
1162
Hecla Mining
HL
$11.9B
$744K 0.01%
227,546
+15,451
+7% +$42.7K
YEXT icon
1163
Yext
YEXT
$613M
$744K 0.01%
44,787
+3,311
+8% +$46.4K
HGV icon
1164
Hilton Grand Vacations
HGV
$3.49B
$742K 0.01%
+37,973
New +$749K
KFY icon
1165
Korn Ferry
KFY
$4.36B
$742K 0.01%
24,155
+1,395
+6% +$39.9K
MC icon
1166
Moelis & Co
MC
$5.21B
$740K 0.01%
23,735
+3,634
+18% +$114K
ALTR
1167
DELISTED
Altair Engineering Inc
ALTR
$739K 0.01%
18,603
+1,359
+8% +$46.2K
FLOW
1168
DELISTED
SPX FLOW, Inc.
FLOW
$738K 0.01%
19,717
+2,390
+14% +$78K
DRNA
1169
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$737K 0.01%
29,035
+6,181
+27% +$133K
KTOS icon
1170
Kratos Defense & Security Solutions
KTOS
$11.8B
$735K 0.01%
47,040
+7,271
+18% +$116K
NWN icon
1171
Northwest Natural Holdings
NWN
$2.14B
$734K 0.01%
13,165
CTRE icon
1172
CareTrust REIT
CTRE
$9.18B
$734K 0.01%
42,777
XRX icon
1173
Xerox
XRX
$412M
$732K 0.01%
47,892
-31
-0.1% -$535
EDIT icon
1174
Editas Medicine
EDIT
$432M
$732K 0.01%
24,752
+3,234
+15% +$84.5K
EVTC icon
1175
Evertec
EVTC
$1.91B
$732K 0.01%
26,041

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.